Zai Lab (ZLAB) Invested Capital (2018 - 2026)
Zai Lab (ZLAB) posted Invested Capital of $213.8 million for Q1 2026, up 4.54% sequentially from $204.5 million in Q4 2025, and up 23.31% YoY from $173.4 million in Q1 2025.
Zai Lab (ZLAB) Invested Capital (2018 - 2026) Analysis & Trends
Zai Lab has reported Invested Capital for 6 years, with the latest figure at $213.8 million in Q1 2026.
- Quarterly Invested Capital rose 23.31% year-over-year to $213.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $795.9 million (up 62.95% YoY) and the FY2025 annual result came in at $204.5 million, up 55.29% from the prior year.
- Invested Capital grew to $213.8 million in Q1 2026 per ZLAB's latest filing, from $204.5 million in the prior quarter.
- Over five years, Invested Capital peaked at $213.8 million in Q1 2026 and troughed at $48.3 million in Q1 2024.
- A 3-year average of $148.1 million and a median of $173.4 million in 2025 frame the typical range for Invested Capital.
- The sharpest annual moves came in 2025 and 2026: Invested Capital surged 259.22% in 2025, then rose 23.31% in 2026.
- Over 3 years, Invested Capital stood at $131.7 million in 2024, then jumped by 55.29% to $204.5 million in 2025, then rose by 4.54% to $213.8 million in 2026.
- According to Business Quant data, Invested Capital over the past three periods registered $213.8 million, $204.5 million, and $203.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 190.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.57 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 380.00 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Zai Lab | 2.91 Bn | 2.20 Bn | 58.15 Mn | 238.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 238.10 Mn |
| Mar 31, 2026 | 213.82 Mn |
| Dec 31, 2025 | 204.53 Mn |
| Sep 30, 2025 | 203.03 Mn |
| Jun 30, 2025 | 174.51 Mn |
| Mar 31, 2025 | 173.41 Mn |
| Dec 31, 2024 | 131.71 Mn |
| Sep 30, 2024 | 112.99 Mn |
| Jun 30, 2024 | 70.30 Mn |
| Mar 31, 2024 | 48.27 Mn |
| Jun 30, 2020 | 4.24 Mn |
| Dec 31, 2019 | 6.45 Mn |
| Sep 30, 2019 | 6.36 Mn |
| Dec 31, 2018 | 3.64 Mn |